These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Antifungals in Clinical Use and the Pipeline. Johnson MD Infect Dis Clin North Am; 2021 Jun; 35(2):341-371. PubMed ID: 34016281 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic implications for use of antifungal agents. Lewis RE Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480 [TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents. Brüggemann RJ; Alffenaar JW; Blijlevens NM; Billaud EM; Kosterink JG; Verweij PE; Burger DM Clin Infect Dis; 2009 May; 48(10):1441-58. PubMed ID: 19361301 [TBL] [Abstract][Full Text] [Related]
13. Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients. Gubbins PO Curr Opin Infect Dis; 2007 Dec; 20(6):579-86. PubMed ID: 17975407 [TBL] [Abstract][Full Text] [Related]
14. Antifungal drug resistance to azoles and polyenes. Masiá Canuto M; Gutiérrez Rodero F Lancet Infect Dis; 2002 Sep; 2(9):550-63. PubMed ID: 12206971 [TBL] [Abstract][Full Text] [Related]
15. A new era of antifungal therapy. Wingard JR; Leather H Biol Blood Marrow Transplant; 2004 Feb; 10(2):73-90. PubMed ID: 14750074 [TBL] [Abstract][Full Text] [Related]